City of Hope Investigational Drug Services (IDS) — Duarte, California

City of Hope Investigational Drug Services (IDS) is a clinical research site located in Duarte, California, United States 91010.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

City of Hope Investigational Drug Services (IDS) has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Early Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for City of Hope Investigational Drug Services (IDS)?

City of Hope Investigational Drug Services (IDS) has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has City of Hope Investigational Drug Services (IDS) conducted?

City of Hope Investigational Drug Services (IDS) has 5 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Early Breast Cancer.

Is City of Hope Investigational Drug Services (IDS) accredited by Crixeo Health?

City of Hope Investigational Drug Services (IDS) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about City of Hope Investigational Drug Services (IDS)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.